The Art of Unlearning: Chlamydia Trachomatis and the Limits of Light Microscopy

Article Sidebar

Global Journal of Medical and Clinical Case Reports Online first articles
PDF HTML
Submitted: July 23, 2026
Published: Aug 4, 2026
DOI: 10.17352/gjmccr.000262
Keywords:
Chlamydia trachomatis, Cervical cytology, Bethesda system, Nucleic acid amplification tests, Molecular diagnostics

Main Article Content

Francisco Javier Torres-Gómez
Dr. Torres Laboratory of Pathology and Cytology (CITADIAG SL), Seville, Spain
Rosa Sánchez de Medina-González
Dr. Torres Laboratory of Pathology and Cytology (CITADIAG SL), Seville, Spain

Abstract

Objective: To evaluate the historical shift from cytological diagnosis to molecular detection of Chlamydia trachomatis, outlining the precise current role of cervical cytology in clinical practice.
Methods: Historical perspectives, updated international clinical guidelines, and recent technological literature were analyzed.
Results: Papanicolaou smear examination for C. trachomatis demonstrates poor sensitivity (<30%) and high false-positive rates caused by degenerative vacuoles and cellular artifacts. Nucleic Acid Amplification Tests (NAATs) represent the current diagnostic standard. Recent advancements in 2025–2026, including multiplex PCR platforms and point-of-care (POC) testing, have further solidified molecular diagnostics.
Conclusions: Cytology should not be used for direct diagnosis or screening of C. trachomatis. However, it remains a valuable tool for neoplastic screening and an indirect indicator of cervical inflammation, prompting targeted molecular testing.

Downloads

Download data is not yet available.

Article Details

Torres-Gómez, F. J., & de Medina-González, R. S. (2026). The Art of Unlearning: Chlamydia Trachomatis and the Limits of Light Microscopy. Global Journal of Medical and Clinical Case Reports, 166–168. https://doi.org/10.17352/gjmccr.000262
Short Communications

Copyright (c) 2026 Torres-Gómez FJ, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Gupta PK, Lee EF, Erozan YS, Frost JK, Geddes S, Donovan PA. Cytologic investigations in Chlamydia infection. Acta Cytol. 1979;23(4):315-20. Available from: https://pubmed.ncbi.nlm.nih.gov/93839/

National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. JAMA. 1989;262(7):931-4. Available from: https://pubmed.ncbi.nlm.nih.gov/2754794/

Kiviat NB, Paavonen JA, Brockway J, et al. Cytological manifestations of cervical Chlamydia trachomatis infection. Acta Cytol. 1985;29(5):671-80.

The 1991 Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. Acta Cytol. 1992;36(3):273-6. Available from: https://pubmed.ncbi.nlm.nih.gov/1580108/

Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114-9. Available from: https://doi.org/10.1001/jama.287.16.2114

Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187. Available from: https://doi.org/10.15585/mmwr.rr7004a1

Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187. Available from: https://doi.org/10.15585/mmwr.rr7004a1

Gaydos CA, Van Der Pol B, Chernesky MA. Advanced point-of-care molecular diagnostics for Chlamydia trachomatis and Neisseria gonorrhoeae: transforming STI management in clinical practice. Clin Infect Dis. 2025;82(Suppl 1).

World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021-2030: accountability for action. Geneva: World Health Organization; 2024.